What are the best predictors for successful GnRH antagonist protocol in in vitro fertilization (IVF) treatment?
暂无分享,去创建一个
N. Samara | Y. Ghetler | O. Gonen | A. Wiser | A. Berkovitz | A. Shulman | Netanella Danielli Miller | D. Reis | Moses Miller
[1] Julie Brown,et al. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. , 2016, The Cochrane database of systematic reviews.
[2] M. Mainigi,et al. Why we should transfer frozen instead of fresh embryos: the translational rationale. , 2014, Fertility and sterility.
[3] H. Qi,et al. Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis , 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology.
[4] P. Patrizio,et al. Fresh transfer outcome predicts the success of a subsequent frozen transfer utilizing blastocysts of the same cohort. , 2014, Reproductive biomedicine online.
[5] M. Boaz,et al. The effect of delayed initiation of gonadotropin-releasing hormone antagonist in a flexible protocol on in vitro fertilization outcome. , 2013, Fertility and sterility.
[6] A. Balen,et al. Timing of human chorionic gonadotrophin (hCG) hormone administration in IVF protocols using GnRH antagonists: a randomized controlled trial , 2012, Human fertility.
[7] G. Garruti,et al. GnRH agonist versus GnRH antagonist in in vitro fertilization and embryo transfer (IVF/ET) , 2012, Reproductive Biology and Endocrinology.
[8] H. Tournaye,et al. Is earlier administration of human chorionic gonadotropin (hCG) associated with the probability of pregnancy in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone (GnRH) antagonists? A prospective randomized trial. , 2011, Fertility and sterility.
[9] C. Simón,et al. Impact of luteinizing hormone administration on gonadotropin-releasing hormone antagonist cycles: an age-adjusted analysis. , 2011, Fertility and sterility.
[10] M. Lane,et al. Avoidance of weekend oocyte retrievals during GnRH antagonist treatment by simple advancement or delay of hCG administration does not adversely affect IVF live birth outcomes. , 2010, Human reproduction.
[11] E. Puscheck,et al. Timing and duration of use of GnRH antagonist down-regulation for IVF/ICSI cycles have no impact on oocyte quality or pregnancy outcomes , 2008, Journal of Assisted Reproduction and Genetics.
[12] E. Kolibianakis,et al. Among patients treated with FSH and GnRH analogues for in vitro fertilization, is the addition of recombinant LH associated with the probability of live birth? A systematic review and meta-analysis. , 2007, Human reproduction update.
[13] H. Tournaye,et al. Administration of gonadotropin-releasing hormone antagonist from day 1 of stimulation in in vitro fertilization. , 2004, Fertility and sterility.
[14] E. Hernández,et al. Embryo implantation and GnRH antagonists: embryo implantation: the Rubicon for GnRH antagonists. , 2000, Human reproduction.
[15] R. Hermann,et al. Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers. , 1998, Human reproduction.
[16] Matheus Roque,et al. Fresh embryo transfer versus frozen embryo transfer in in vitro fertilization cycles: a systematic review and meta-analysis. , 2013, Fertility and sterility.
[17] M. Mann,et al. Dual effects of superovulation: loss of maternal and paternal imprinted methylation in a dose-dependent manner. , 2010, Human molecular genetics.
[18] H. Al-Inany. Clinical consequences of ovarian stimulation in assisted conception and in PCOS , 2006 .